Bandhan BSE Healthcare Index Fund Regular Plan - Growth
Category: Index Fund
Launch Date: 06-09-2024
AUM:
₹ 18.2 Cr
Expense Ratio
1.01%
Benchmark
BSE Healthcare TRI
ISIN
INF194KB1IS2
Minimum Investment
1000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Mr. Nemish Sheth
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| Bandhan BSE Healthcare Index Fund Regular Plan - Growth | - | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
10.1011
Last change
0.04 (0.4049%)
Fund Size (AUM)
₹ 18.2 Cr
Performance
1.32% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in the underlying securities in the same proportion, subject to tracking error. The BSE Healthcare Index will track the performance of companiesthat are part of BSE AllCap belonging to the Healthcare sector.
Fund Manager
Mr. Nemish Sheth
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 14.23 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 6.62 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 6.53 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 6.5 |
| Dr. Reddys Laboratories Ltd | 5.99 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 5.43 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 3.72 |
| FORTIS HEALTHCARE LIMITED. EQ | 2.89 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 2.61 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 2.51 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 100.11 |